(EOLS) Evolus - Performance -11.1% in 12m
EOLS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
36.17%
#27 in Peer-Group
Rel. Strength
26.74%
#5624 in Stock-Universe
Total Return 12m
-11.14%
#119 in Peer-Group
Total Return 5y
217.97%
#9 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 154 |
| High / Low | USD |
|---|---|
| 52 Week High | 17.49 USD |
| 52 Week Low | 9.10 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 67.86 |
| Buy/Sell Signal +-5 | 0.60 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: EOLS (-11.1%) vs XLV (-5.3%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.36% | 135% | 355% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.34% | 16.6% | 86.1% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-2.05% | -15.3% | 417% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.68% | 4.53% | 55.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-4.16% | 7.17% | 55.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-2.74% | -5.77% | 51.3% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-8.26% | -8.51% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
4.73% | 19.8% | 64.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: EOLS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for EOLS
| Total Return (including Dividends) | EOLS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -1.42% | 0.95% | 4.08% |
| 3 Months | 3.35% | 1.54% | 19.65% |
| 12 Months | -11.14% | -5.25% | 12.88% |
| 5 Years | 217.97% | 45.67% | 113.48% |
| Trend Score (consistency of price movement) | EOLS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -52% | 24.8% | 86.9% |
| 3 Months | -71.4% | -21.1% | 97.2% |
| 12 Months | -66.3% | -78.2% | 46% |
| 5 Years | 56.1% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th35.00 | -2.35% | -5.28% |
| 3 Month | %th21.50 | 1.78% | -13.63% |
| 12 Month | %th40.50 | -6.22% | -21.28% |
| 5 Years | %th95.50 | 118.28% | 48.95% |
FAQs
Does Evolus (EOLS) outperform the market?
No,
over the last 12 months EOLS made -11.14%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.25%.
Over the last 3 months EOLS made 3.35%, while XLV made 1.54%.
Performance Comparison EOLS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
EOLS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.9% | -5.5% | -11.2% | -24% |
| US NASDAQ 100 | QQQ | 5.1% | -5.5% | -12.5% | -22% |
| German DAX 40 | DAX | 2.8% | -3.3% | -23.2% | -43% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.5% | -6.7% | -15.5% | -32% |
| Hongkong Hang Seng | HSI | 6.1% | -3.9% | -31.4% | -48% |
| India NIFTY 50 | INDA | 5.9% | -1.4% | -10.6% | -9% |
| Brasil Bovespa | EWZ | 10.4% | -3.3% | -27.2% | -14% |
EOLS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.2% | -3.6% | -14.7% | -34% |
| Consumer Discretionary | XLY | 4.9% | -3.9% | -3.4% | -28% |
| Consumer Staples | XLP | 6.3% | -1.3% | -10.2% | -19% |
| Energy | XLE | 3% | -6.6% | -4.7% | -14% |
| Financial | XLF | 5.9% | -5% | -14.9% | -39% |
| Health Care | XLV | 4.4% | -2.4% | -1.2% | -6% |
| Industrial | XLI | 4.1% | -6.3% | -18.2% | -37% |
| Materials | XLB | 4% | -5.7% | -14.6% | -18% |
| Real Estate | XLRE | 5.4% | -0.8% | -10.6% | -22% |
| Technology | XLK | 5% | -8.3% | -15.4% | -20% |
| Utilities | XLU | 4.1% | -4.2% | -13.5% | -33% |
| Aerospace & Defense | XAR | 4.6% | -7.9% | -29.3% | -60% |
| Biotech | XBI | 1.3% | -5.1% | -1.5% | -4% |
| Homebuilder | XHB | 1.6% | -9.8% | -6.8% | -17% |
| Retail | XRT | 4.6% | -4.2% | -5.6% | -22% |
EOLS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.7% | -6.71% | 3.81% | -5% |
| Natural Gas | UNG | 8.2% | 6.7% | 17.2% | -6% |
| Gold | GLD | 5.3% | -1.3% | -26.1% | -51% |
| Silver | SLV | 4.2% | -3% | -24.9% | -31% |
| Copper | CPER | -4.1% | -14.8% | -32.1% | -34% |
EOLS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.9% | -3.1% | -6.7% | -9% |
| iShares High Yield Corp. Bond | HYG | 5.3% | -2.7% | -7.7% | -21% |